# BREVOC Study: Exhaled VOCs for High-Risk Chest Pain in the ED

> **NCT07379567** · — · NOT_YET_RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 6000 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- High-Risk Chest Pain
- Volatile Organic Compounds

## Interventions

- **DIAGNOSTIC_TEST:** observational study

## Key facts

- **NCT ID:** NCT07379567
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 6000 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07379567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07379567, "BREVOC Study: Exhaled VOCs for High-Risk Chest Pain in the ED". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07379567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*